Skip to main content

Advertisement

Table 2 Product characteristics and average price levelsa

From: Generic prescription drug price increases: which products will be affected by proposed anti-gouging legislation?

Product characteristic Percent of products (N = 6,182) Mean (SD) USD Price Level in 2013
Manufacturer Count per Product
 1 27% 92.90 (721.02)
 2 6% 23.47 (108.27)
 3 8% 16.13 (71.54)
 4 6% 8.79 (37.44)
 ≥ 5 53% 2.65 (16.94)
Formulation
 All Others 22% 41.23 (526.71)
 Injectable 14% 133.76 (753.03)
 Oral 64% 2.63 (14.24)
Patent Status
 Branded Generic 21% 112.03 (822.57)
 Generic 79% 8.36 (54.11)
Volume in previous period
 Very low volume (<1,000 units per quarter) 10% 142.14 (1,077.18)
 All other drugs 90% 17.65 (186.61)
Orphan Drug Designation
 No 92% 13.53 (78.45)
 Yes 8% 214.16 (1,293.70)
  1. aAuthors’ calculations using IQVIA Health NSP data. All analyses used STATA 14.0 (College Station, Texas)